keyword
https://read.qxmd.com/read/38650383/current-strategies-for-targeting-hpk1-in-cancer-and-the-barriers-to-preclinical-progress
#21
JOURNAL ARTICLE
Hui Chen, Xiangna Guan, Chi He, Tingting Lu, Xingyu Lin, Xuebin Liao
INTRODUCTION: Hematopoietic progenitor kinase 1 (HPK1), a 97-kDa serine/threonine Ste20-related protein kinase, functions as an intracellular negative regulator, primarily in hematopoietic lineage cells, where it regulates T cells, B cells, dendritic cells and other immune cells. Loss of HPK1 kinase activity results in exacerbated cytokine secretion, enhanced T cell signaling, improved viral clearance, and thus increased restraint of tumor growth. These findings highlight HPK1 as a promising target for immuno-oncology treatments, culminating in the advancement of candidate compounds targeting HPK1 to clinical trials by several biotech enterprises...
April 22, 2024: Expert Opinion on Therapeutic Targets
https://read.qxmd.com/read/38649936/clinical-significance-of-urinary-inflammatory-biomarkers-in-patients-with-iga-nephropathy
#22
JOURNAL ARTICLE
Soo-Young Yoon, Jin Sug Kim, Su Woong Jung, Yang Gyun Kim, Ju-Young Moon, Sang-Ho Lee, Sung-Vin Yim, Hyeon Seok Hwang, Kyunghwan Jeong
BACKGROUND: IgA nephropathy (IgAN) is the most common type of primary glomerulonephritis, although the definitive markers are unknown. We aimed to investigate the clinical significance of urinary cytokines in patients with IgAN. METHODS: From 2009 to 2018, the patients were divided into three groups: IgAN (n = 191), disease control (n = 53), and normal control (n = 76). We used a multiplex enzyme-linked immunosorbent assay to measure 16 selected urinary inflammatory cytokines, evaluated the correlation between clinical and pathological features following regression analysis on progression...
April 22, 2024: BMC Nephrology
https://read.qxmd.com/read/38649626/pdx-models-in-theranostic-applications-generation-and-screening-for-b-cell-lymphoma-of-human-origin
#23
JOURNAL ARTICLE
Shayla Shmuel, Sébastien Monette, Dina Ibrahim, Patrícia M R Pereira
This MIB guide briefly summarizes the generation of patient-derived xenografts (PDXs) and highlights the importance of validating PDX models for the presence of B cell lymphoma of human origin before their use in radiotheranostic applications. The use of this protocol will allow researchers to learn different methods for screening PDX models for Epstein-Barr virus (EBV)-infected B cell lymphoma.
April 22, 2024: Molecular Imaging and Biology: MIB: the Official Publication of the Academy of Molecular Imaging
https://read.qxmd.com/read/38649462/disulfiram-treatment-suppresses-antibody-producing-reactions-by-inhibiting-macrophage-activation-and-b-cell-pyrimidine-metabolism
#24
JOURNAL ARTICLE
Weili Chen, Etsuko Toda, Kazuhiro Takeuchi, Yurika Sawa, Kyoko Wakamatsu, Naomi Kuwahara, Arimi Ishikawa, Yuri Igarashi, Mika Terasaki, Shinobu Kunugi, Yasuhiro Terasaki, Kazuhiko Yamada, Yuya Terashima, Akira Shimizu
Antibody responses, involving B cells, CD4 + T cells, and macrophages, are implicated in autoimmune diseases and organ transplant rejection. We have previously shown that inhibiting FROUNT with disulfiram (DSF) suppresses macrophage activation and migration, effectively treating inflammatory diseases. In this study, we investigated the effectiveness of DSF in antibody-producing reactions. Using a heart transplantation mouse model with antibody-mediated rejection, we administered anti-CD8 antibody to exclude cellular rejection...
April 22, 2024: Communications Biology
https://read.qxmd.com/read/38649412/interferon-induced-transmembrane-protein-1-competitively-blocks-ephrin-receptor-a2-mediated-epstein-barr-virus-entry-into-epithelial-cells
#25
JOURNAL ARTICLE
Yinggui Yang, Tengteng Ding, Ying Cong, Xiaomin Luo, Changlin Liu, Ting Gong, Min Zhao, Xichun Zheng, Chenglin Li, Yuanbin Zhang, Jiayi Zhou, Chuping Ni, Xueyu Zhang, Ziliang Ji, Tao Wu, Shaodong Yang, Qingchun Zhou, Dinglan Wu, Xinqi Gong, Qingyou Zheng, Xin Li
Epstein-Barr virus (EBV) can infect both B cells and epithelial cells (ECs), causing diseases such as mononucleosis and cancer. It enters ECs via Ephrin receptor A2 (EphA2). The function of interferon-induced transmembrane protein-1 (IFITM1) in EBV infection of ECs remains elusive. Here we report that IFITM1 inhibits EphA2-mediated EBV entry into ECs. RNA-sequencing and clinical sample analysis show reduced IFITM1 in EBV-positive ECs and a negative correlation between IFITM1 level and EBV copy number. IFITM1 depletion increases EBV infection and vice versa...
April 22, 2024: Nature Microbiology
https://read.qxmd.com/read/38649144/identification-of-tfg-and-autophagy-regulated-proteins-and-glycerophospholipids-in-b-cells
#26
JOURNAL ARTICLE
Tobit D Steinmetz, Jana Thomas, Lena Reimann, Ann-Kathrin Himmelreich, Sebastian R Schulz, Florian Golombek, Kathrin Castiglione, Hans-Martin Jäck, Susanne Brodesser, Bettina Warscheid, Dirk Mielenz
Autophagy supervises the proteostasis and survival of B lymphocytic cells. Trk-fused gene (TFG) promotes autophagosome-lysosome flux in murine CH12 B cells, as well as their survival. Hence, quantitative proteomics of CH12 tfg KO and WT B cells in combination with lysosomal inhibition should identify proteins that are prone to lysosomal degradation and contribute to autophagy and B cell survival. Lysosome inhibition via NH4 Cl unexpectedly reduced a number of proteins but increased a large cluster of translational, ribosomal, and mitochondrial proteins, independent of TFG...
April 22, 2024: Journal of Proteome Research
https://read.qxmd.com/read/38648957/cadherin-11-targeted-cell-specific-liposomes-enabled-skin-fibrosis-treatment-by-inducing-apoptosis
#27
JOURNAL ARTICLE
Himanshu N Bhatt, Rimpy Diwan, Igor L Estevao, Rui Dong, Jennifer Smith, Chuan Xiao, Sandeep K Agarwal, Md Nurunnabi
Continuous and aberrant activation of myofibroblasts is the hallmark of pathological fibrosis (e.g., abnormal wound healing). The deposition of excessive extracellular matrix (ECM) components alters or increases the stiffness of tissue and primarily accounts for multiple organ dysfunctions. Among various proteins, Cadherin-11 (CDH11) has been reported to be overexpressed on myofibroblasts in fibrotic tissues. Anti-apoptotic proteins such as (B cell lymphoma-2) (BCL-2) are also upregulated on myofibroblasts...
April 20, 2024: Journal of Controlled Release
https://read.qxmd.com/read/38648564/testing-for-t-3-8-in-myc-bcl6-re-arranged-large-b-cell-lymphoma-identifies-a-high-risk-subgroup-with-inferior-survival
#28
JOURNAL ARTICLE
Bernard Douglas Maybury, Lisa Jane James, Neil Phillips, Indrani Venkatadasari, Iman Qureshi, James William Elliot Riley, Georgina Talbot, Shivir Moosai, Hannah Victoria Giles, Nicola Chadderton, James Dowds, Pallav Rakesh, Henry Crosland, Aidan Haslam, Sarah Lane, Monica Vega Gonzalez, David Davies, George Cherian, Amir Shenouda, Praveen Kumar Kaudlay Sathyanarayana, Jane Starczynski, Zbigniew Rudzki, Sridhar Chaganti
A reciprocal t(3;8) BCL6::MYC fusion is common in large B cell lymphoma (LBCL) with MYC and BCL6 disruption. These pseudo-double hit cases are not adverse, whereas t(3;8) negative MYC/BCL6 lymphoma has an inferior prognosis relative to other MYC-rearranged LBCL.
April 22, 2024: Blood
https://read.qxmd.com/read/38648512/landscape-and-prognostic-values-of-lymphocytes-in-patients-with-hepatocellular-carcinoma-undergoing-transarterial-embolization
#29
JOURNAL ARTICLE
Rui-Dong Zhao, Ding-Jie Liu, Jia-Wei Li, Yong Wang, Jun-Hao Lin, Yi-Tian Zhang, Yong Li, Mei-Xiao Zhan, Zhi-Nan Yin, Li-Gong Lu, Bing Liu
Transarterial embolization (TACE), the first-line treatment for hepatocellular carcinoma (HCC), does not always lead to promising outcomes in all patients. A better understanding of how the immune lymphocytes changes after TACE might be the key to improve the efficacy of TACE. However, there are few studies evaluating immune lymphocytes in TACE patients. Therefore, we aimed to evaluate the short- and long-term effects of TACE on lymphocyte subsets in patients with HCC to identify those that predict TACE prognosis...
April 22, 2024: Journal of Leukocyte Biology
https://read.qxmd.com/read/38648045/richter-syndrome-presenting-as-subcutaneous-nodules-and-a-dermal-plaque
#30
JOURNAL ARTICLE
Melissa Nickles, Samantha Hunt, Saul Turcios-Escobar, Amaara Babwah, Nisreen Mobayed, Carlos Murga-Zamalloa, Michelle Bain, John Quigley, Paul Rubinstein, Carlos Galvez
Richter syndrome (RS) describes a phenomenon in which a patient with chronic lymphocytic leukemia (CLL) develops an aggressive lymphoma, most commonly diffuse large B-cell lymphoma (DLBCL). Reports of cutaneous RS remain exceedingly rare. We report a 61-year-old woman with relapsed/refractory CLL presenting with several subcutaneous nodules on her arms and legs and a single dermal plaque on her abdomen. Skin biopsy revealed a diagnosis of DLBCL, ABC-type, and her clinical status rapidly deteriorated following diagnosis...
April 23, 2024: American Journal of Dermatopathology
https://read.qxmd.com/read/38647373/glycan-reactive-innate-like-b-cells-and-developmental-checkpoints
#31
JOURNAL ARTICLE
J Stewart New, Brian L P Dizon, John F Kearney, R Glenn King
Using an Ig H chain conferring specificity for N-acetyl-d-glucosamine (GlcNAc), we developed transgenic (VHHGAC39 TG) mice to study the role of self-antigens in GlcNAc-reactive B-1 B cell development. In VHHGAC39 TG mice, GlcNAc-reactive B-1 B cell development during ontogeny and in adult bone marrow was normal. However, adult TG mice exhibited a block at transitional-2 immature B cell stages, resulting in impaired allelic exclusion and accumulation of a B cell subset coexpressing endogenous Ig gene rearrangements...
April 22, 2024: Journal of Immunology
https://read.qxmd.com/read/38647337/targeting-t-bet-expressing-b-cells-for-therapeutic-interventions-in-autoimmunity
#32
JOURNAL ARTICLE
Athanasios Sachinidis, Malamatenia Lamprinou, Theodoros Dimitroulas, Alexandros Garyfallos
Apart from serving as a Th1 lineage commitment regulator, transcription factor T-bet is also expressed in other immune cell types and thus orchestrates their functions. In case of B cells, more specifically, T-bet is responsible for their isotype switching to specific IgG sub-classes (IgG2a/c in mice and IgG1/3 in humans). In various autoimmune disorders, such as systemic lupus erythematosus and/or rheumatoid arthritis, subsets of T-bet expressing B cells, known as age-associated B cells (CD19+CD11c+CD21-T-bet+) and/or double-negative B cells (CD19+IgD-CD27-T-bet+), display an expansion and seem to drive disease pathogenesis...
April 22, 2024: Clinical and Experimental Immunology
https://read.qxmd.com/read/38647163/tumor-associated-macrophages-and-tumor-infiltrating-lymphocytes-in-canine-cutaneous-and-subcutaneous-mast-cell-tumors
#33
JOURNAL ARTICLE
Luca Bertola, Benedetta Pellizzoni, Chiara Giudice, Valeria Grieco, Roberta Ferrari, Lavinia E Chiti, Damiano Stefanello, Martina Manfredi, Donatella De Zani, Camilla Recordati
Cutaneous and subcutaneous mast cell tumors (MCTs) are common canine neoplasms characterized by variable biological behavior. Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) can be effective prognostic markers in numerous human neoplasms and are increasingly investigated in dogs. The aim of this study was to characterize immune cells in canine MCTs and their relationship with histological location (cutaneous, subcutaneous) and histologic nodal metastatic status (HN0-3). Thirty-eight MCTs (26 cutaneous, 12 subcutaneous) from 33 dogs with known sentinel lymph node (SLN) metastatic status were immunolabeled for Iba1 (macrophages), CD20 (B cells), CD3 (T cells), and Foxp3 (regulatory T cells)...
April 22, 2024: Veterinary Pathology
https://read.qxmd.com/read/38646949/extended-interval-dosing-with-ocrelizumab-in-multiple-sclerosis
#34
JOURNAL ARTICLE
Frederik Novak, Hamza Mahmood Bajwa, Kamilla Østergaard, Jonas Munksgaard Berg, Jonna Skov Madsen, Dorte Aalund Olsen, Inga Urbonaviciute, Zsolt Illes, Morten Leif Stilund, Jeppe Romme Christensen, Stephan Bramow, Finn Sellebjerg, Tobias Sejbaek
BACKGROUND: This study investigates clinical and biomarker differences between standard interval dosing (SID) and extended interval dosing (EID) of ocrelizumab therapy in multiple sclerosis (MS). METHODS: This is a prospective, double-arm, open-label, multi-center study in Denmark. Participants diagnosed with MS on ocrelizumab therapy >12 months were included ( n = 184). Clinical, radiological, and blood-based biomarker outcomes were evaluated. MRI disease activity, relapses, worsening of neurostatus, and No Evidence of Disease Activity-3 (NEDA-3) were used as a combined endpoint...
April 22, 2024: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/38646803/clinicopathological-role-of-cyclin-a2-in-uterine-corpus-endometrial-carcinoma-integration-of-tissue-microarrays-and-scrna-seq
#35
JOURNAL ARTICLE
Wei-Jia Mo, Zi-Qian Liang, Jie-Zhuang Huang, Zhi-Guang Huang, Zhi-Fu Zhi, Jun-Hong Chen, Gang Chen, Jing-Jing Zeng, Zhen-Bo Feng
BACKGROUND: The comprehensive expression level and potential molecular role of Cyclin A2 (CCNA2) in uterine corpus endometrial carcinoma (UCEC) remains undiscovered. METHODS: UCEC and normal endometrium tissues from in-house and public databases were collected for investigating protein and messenger RNA expression of CCNA2. The transcription factors of CCNA2 were identified by the Cistrome database. The prognostic significance of CCNA2 in UCEC was evaluated through univariate and multivariate Cox regression as well as Kaplan-Meier curve analysis...
April 22, 2024: International Journal of Biological Markers
https://read.qxmd.com/read/38646700/network-meta-analysis-of-car-t-cell-therapy-for-the-treatment-of-3l-r-r-lbcl-after-using-published-comparative-studies
#36
REVIEW
Olalekan O Oluwole, Sattva S Neelapu, Markqayne D Ray, Eve H Limbrick-Oldfield, Sally W Wade, Steve Kanters, Anik R Patel, Frederick L Locke
INTRODUCTION: Studies have compared chimeric antigen receptor (CAR) T-cell therapies and salvage chemotherapy in relapsed/refractory large B-cell lymphoma (LBCL) patients, but further evidence of their relative effectiveness is warranted. METHODS: Our systematic review identified studies comparing efficacy and safety outcomes of axicabtagene ciloleucel (axi-cel), lisocabtagene maraleucel (liso-cel) and tisagenlecleucel (tisa-cel) trials to salvage chemotherapy cohorts in LBCL patients with ≥ 2 prior lines of treatment; and an extended evidence network included indirect comparisons comparing CAR T-cell therapies...
April 22, 2024: Expert Review of Anticancer Therapy
https://read.qxmd.com/read/38646695/immune-reconstitution-in-children-after-haploidentical-haematopoietic-stem-cell-transplantation
#37
JOURNAL ARTICLE
Saranthorn Apasuthirat, Nopporn Apiwattanakul, Usanarat Anurathapan, Nintita Sripaiboonkij Thokanit, Karan Paisooksantivatana, Ekawat Pasomsub, Suradej Hongeng, Samart Pakakasama
INTRODUCTION: Immune reconstitution (IR) kinetics of paediatric patients underwent haploidentical haematopoietic stem cell transplantation (HSCT) with post-transplant cyclophosphamide (PTCy) have not been extensively studied. We compared IR patterns of children receiving HSCT from haploidentical (n = 92) and HLA-matched donors (n = 36), and analysed risk factors for viral infection in these patients. METHODS: We prospectively measured lymphocyte subset numbers before HSCT and at 1, 3, 6 and 12 months after HSCT...
April 22, 2024: International Journal of Laboratory Hematology
https://read.qxmd.com/read/38646539/pathways-and-molecules-for-overcoming-immunotolerance-in-metastatic-gastrointestinal-tumors
#38
REVIEW
Qixin Gan, Yue Li, Yuejun Li, Haifen Liu, Daochuan Chen, Lanxiang Liu, Churan Peng
Worldwide, gastrointestinal (GI) cancer is recognized as one of the leading malignancies diagnosed in both genders, with mortality largely attributed to metastatic dissemination. It has been identified that in GI cancer, a variety of signaling pathways and key molecules are modified, leading to the emergence of an immunotolerance phenotype. Such modifications are pivotal in the malignancy's evasion of immune detection. Thus, a thorough analysis of the pathways and molecules contributing to GI cancer's immunotolerance is vital for advancing our comprehension and propelling the creation of efficacious pharmacological treatments...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38646528/itgal-expression-in-non-small-cell-lung-cancer-tissue-and-its-association-with-immune-infiltrates
#39
JOURNAL ARTICLE
Ruihao Zhang, Guangsheng Zhu, Zaishan Li, Zhenzhen Meng, Hua Huang, Chen Ding, Yanan Wang, Chen Chen, Yongwen Li, Hongyu Liu, Jun Chen
BACKGROUND: Integrin subunit alpha L (ITGAL) encodes an integrin component of LFA-1 and is a membrane receptor molecule widely expressed on leukocytes. It plays a key role in the interaction between white blood cells and other cells. There was a significant correlation between the expression of ITGAL and the tumor microenvironment in a number of cancers. However, experimental studies targeting ITGAL and immune cell infiltration in non-small-cell lung cancer (NSCLC) and the response to immune checkpoint inhibitor therapy are lacking...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38646525/memory-b-cell-derived-donor-specific-antibodies-do-not-predict-outcome-in-sensitized-kidney-transplant-recipients-a-retrospective-single-center-study
#40
JOURNAL ARTICLE
Dania Altulea, Joost C van den Born, Arjan Diepstra, Laura Bungener, Dagmar Terpstra, Bouke G Hepkema, Rosa Lammerts, Peter Heeringa, Sebastiaan Heidt, Henny Otten, Leon Reteig, Gonca E Karahan, Stefan P Berger, Jan-Stephan Sanders
BACKGROUND: Repeated exposure to sensitizing events can activate HLA-specific memory B cells, leading to the production of donor-specific memory B cell antibodies (DSAm) that pose a risk for antibody-mediated rejection (ABMR) in kidney transplant recipients (KTRs). This single-center retrospective study aimed to identify DSAm and assess their association with outcomes in a cohort of KTRs with pretransplant serum donor-specific antibodies (DSA). METHODS: We polyclonally activated pretransplant peripheral blood mononuclear cells (PBMCs) from 60 KTRs in vitro, isolated and quantified IgG from the culture supernatant using ELISA, and analyzed the HLA antibodies of eluates with single antigen bead (SAB) assays, comparing them to the donor HLA typing for potential DSAm...
2024: Frontiers in Immunology
keyword
keyword
41345
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.